FIELD: medicine.
SUBSTANCE: correcting the neurotoxic action of administering the preparation dapsone is ensured by using alpha tocopherol acetate as a correcting agent. Alpha tocopherol acetate is administered per os in a combination with dapsone to non-linear male and female white rats in a dose of 5 mg/kg once a day for 21 day.
EFFECT: using the method enables providing more effective correction of the neurotoxic side actions of dapsone with no side effects.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| METHOD OF MODELLING CHRONIC FATIGUE IN EXPERIMENT | 2010 |
|
RU2449379C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| QUINAZOLIN-4(3H)-ONE DIMETHOXYBENZYLSULFO DERIVATIVE WITH ANALGESIC, ANTIPARKINSONIAN, ANXIOLYTIC, PSYCHOSTIMULATING ACTIVITY | 2021 |
|
RU2758333C1 |
| NEW N-ARYLSULPHAMIDE DERIVATIVE OF O-BENZOILAMINE-BENZOIC ACID WITH ANXIOLYTIC, ACTOPROTECTIVE AND ANTIDEPRESSANT ACTIVITY | 2016 |
|
RU2643356C2 |
| MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| METHOD OF NEUROIMMUNE DISORDER CORRECTION IN EXPERIMENTAL IMMUNOPATHOLOGY | 2010 |
|
RU2429835C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
